ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Technology Services

M3, Inc.

Business Summary

M3, Inc. engages in the provision of medical related services through the Internet. It operates through the following segments: Medical Platform, Evidence Solution, Career Solution, Site Solution, Overseas, and Other Emerging Businesses. The Medical Platform segment handles domestic marketing-related services that uses the Internet. It also operates the medical professional site, m3.com. The Evidence Solution segment offers business support for clinical trials. It also manages overall clinical trial operations. The Career Solution segment deals with human resources service business for medical professionals in Japan. The Site Solutions segment covers medical institution management support and home-visit nursing businesses. The Overseas segment provides services such as marketing support, research, clinical trial support, and human resources services for medical companies that use medical professional sites in the United States, United Kingdom, China, South Korea, India, France, Germany, and Spain. The Other Emerging Businesses segment includes consumer services, and medical and welfare national examination preparation services. The company was founded on September 29, 2000 and is headquartered in Tokyo, Japan.

Financial Highlights

Mar 2022 JPYUSD
Revenue208,159M1,852.39M
Gross Profit123,268M1,096.95M
Operating income67,201M598.01M
Income before tax98,617M877.58M
Net income63,845M568.15M
EBITDA73,475M653.85M
Diluted EPS93.980.83
Dividends Per Share160.14
Total Assets345,981M2,850.51M
Total liabilities82,027M675.81M
Total equity257,840M2,124.32M
Operating cash flow52,108M463.70M
Currency in JPYCurrency in USD

Historical Data

 Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022
Revenue 94,471M 113,059M 130,973M 169,198M 208,159M
Gross Profit 53,016M 62,884M 69,759M 99,268M 123,268M
Operating income 26,907M 27,837M 34,294M 58,362M 67,201M
Income before tax 27,472M 30,942M 34,610M 58,292M 98,617M
Net income 18,127M 19,577M 21,635M 37,822M 63,845M
EBITDA 28,068M 29,228M 38,788M 64,099M 73,475M
Diluted EPS 27.97 30.20 31.87 55.67 93.98
Dividends Per Share 5.50 7 8.50 12 16
Total Assets 116,441M 137,306M 221,839M 273,123M 345,981M
Total liabilities 31,272M 35,029M 50,238M 65,863M 82,027M
Total equity 82,483M 98,733M 166,111M 199,813M 257,840M
Operating cash flow 15,913M 17,749M 26,789M 46,627M 52,108M
 Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022
Revenue 852.37M 1,019.51M 1,204.61M 1,595.34M 1,852.39M
Gross Profit 478.34M 567.06M 641.60M 935.98M 1,096.95M
Operating income 242.77M 251.02M 315.41M 550.28M 598.01M
Income before tax 247.86M 279.02M 318.32M 549.62M 877.58M
Net income 163.55M 176.53M 198.98M 356.61M 568.15M
EBITDA 253.24M 263.56M 356.75M 604.38M 653.85M
Diluted EPS 0.25 0.27 0.29 0.52 0.83
Dividends Per Share 0.04 0.06 0.07 0.11 0.14
Total Assets 1,094.88M 1,240.51M 2,054.92M 2,471.70M 2,850.51M
Total liabilities 294.04M 316.47M 465.36M 596.04M 675.81M
Total equity 775.58M 892.01M 1,538.70M 1,808.26M 2,124.32M
Operating cash flow 143.57M 160.05M 246.39M 439.63M 463.70M

Valuation Measures

Mar 2022
PER47.51
ROA20.62%
ROE27.90%
Operating margin32.28%
Profit margin30.67%

Key executives

  • President & Representative Director: Itaru Tanimura
  • Director: Eiji Tsuchiya

Shareholders

  • Sony Group Corp. (33.9%)
  • Baillie Gifford & Co. (8.2%)
  • Nomura Asset Management Co., Ltd. (5.4%)
  • Nippon Telegraph & Telephone Corp. (2.9%)
  • TANIMURA ITARU (2.8%)
  • Nikko Asset Management Co., Ltd. (2.6%)
  • Daiwa Asset Management Co. Ltd. (2.4%)
  • Capital Research & Management Co. (World Investors) (2.1%)
  • Sumitomo Mitsui Trust Asset Management Co., Ltd. (2.0%)
  • The Vanguard Group, Inc. (1.6%)

Contact Details

  • Website:http://corporate.m3.com
  • Address: Akasaka Intercity, 10/F, 1-11-44 Akasaka, Tokyo, 107-0052, Japan
  • Phone: +81.3.6229.8900

Related Companies

  • M3, Inc. (Fund OPD)
  • Towa Sangyo Co., Ltd. (Osaka)
  • ONEhealth Communications Ltd.
  • Vidal France SA
  • M3 (EU) Ltd.
  • M3 Medical Holdings Ltd.
  • Medical Agency KK
  • Edanz Group Japan, Inc.
  • Neuroglia Health Pvt Ltd.
  • Shin Nippon Biomedical Laboratories SMO Ltd.
  • iG-Holdings, Inc. (Japan)
  • M3 Doctor Support, Inc.
  • M3i, Inc.
  • Clinical Porter, Inc.
  • Nouvelle Place, Inc.
  • M3 Marketing, Inc.
  • DailyRounds, Inc.
  • e- SMO KK
  • M Cube, Inc.
  • MirVracha LLC
  • Fuji CRS KK
  • QLife, Inc.
  • M3 USA Corp.
  • C.M.S Co. Ltd.
  • Nihon Ultmarc, Inc.
  • Cosmotec Co., Ltd.
  • SmartestDoc LLC
  • Neues Co. Ltd.
  • Manthan Software Services Pvt Ltd.
  • MIC Medical Corp.

Competitors

  • MedPeer, Inc.
Last Updated on 18 May, 2022

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more